Share Email Print

Proceedings Paper

Biomodulation of light on cells in laser surgery
Author(s): Timon Cheng-Yi Liu; Yan Li; Rui Duan; Xiongwei Cai
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

In laser surgery, it has been observed pulsed 532-nm laser can avoid postoperative purpura, but pulsed 585-nm, 595-nm or 600-nm lasers nonetheless cause purpura when they were used to treat port-wine stains; the XeCl excimer laser (308 nm) can safely and effectively clear psoriasis; both XeCl excimer laser and Ho:YAG laser were used in coronary interventions, but only former was approved by the FDA; open channels after ultraviolet (UV) laser treatment and closed channels with infrared (IR) lasers for transmyocardial laser revascularization; and so on. In this paper, the biological information model of low intensity laser (BIML) is extended to include UVA biomodulation and is used to understand these phenomena. Although the central intensity of the laser beam is so intense that it destroys the tissue, the edge intensity is so low that it can induce biomodulation. Our investigation showed that biomodulation of light on cells might play an important role in the long-term effects of laser surgery.

Paper Details

Date Published: 12 April 2002
PDF: 4 pages
Proc. SPIE 4536, International Workshop on Photonics and Imaging in Biology and Medicine, (12 April 2002); doi: 10.1117/12.462536
Show Author Affiliations
Timon Cheng-Yi Liu, South China Normal Univ. and Huazhong Univ. of Science and Technology (China)
Yan Li, South China Normal Univ. (China)
Rui Duan, South China Normal Univ. (China)
Xiongwei Cai, South China Normal Univ. (China)

Published in SPIE Proceedings Vol. 4536:
International Workshop on Photonics and Imaging in Biology and Medicine
Qingming Luo; Britton Chance; Valery V. Tuchin, Editor(s)

© SPIE. Terms of Use
Back to Top